Cargando…
Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241720/ https://www.ncbi.nlm.nih.gov/pubmed/37273015 http://dx.doi.org/10.1007/s00240-023-01455-1 |
| _version_ | 1785054050244362240 |
|---|---|
| author | Goldfarb, David S. Lieske, John C. Groothoff, Jaap Schalk, Gesa Russell, Kerry Yu, Shuli Vrhnjak, Blaz |
| author_facet | Goldfarb, David S. Lieske, John C. Groothoff, Jaap Schalk, Gesa Russell, Kerry Yu, Shuli Vrhnjak, Blaz |
| author_sort | Goldfarb, David S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10241720 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102417202023-06-07 Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) Goldfarb, David S. Lieske, John C. Groothoff, Jaap Schalk, Gesa Russell, Kerry Yu, Shuli Vrhnjak, Blaz Urolithiasis Correction Springer Berlin Heidelberg 2023-06-05 2023 /pmc/articles/PMC10241720/ /pubmed/37273015 http://dx.doi.org/10.1007/s00240-023-01455-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Goldfarb, David S. Lieske, John C. Groothoff, Jaap Schalk, Gesa Russell, Kerry Yu, Shuli Vrhnjak, Blaz Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) |
| title | Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) |
| title_full | Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) |
| title_fullStr | Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) |
| title_full_unstemmed | Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) |
| title_short | Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) |
| title_sort | correction to: nedosiran in primary hyperoxaluria subtype 3: results from a phase i, single-dose study (phyox4) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241720/ https://www.ncbi.nlm.nih.gov/pubmed/37273015 http://dx.doi.org/10.1007/s00240-023-01455-1 |
| work_keys_str_mv | AT goldfarbdavids correctiontonedosiraninprimaryhyperoxaluriasubtype3resultsfromaphaseisingledosestudyphyox4 AT lieskejohnc correctiontonedosiraninprimaryhyperoxaluriasubtype3resultsfromaphaseisingledosestudyphyox4 AT groothoffjaap correctiontonedosiraninprimaryhyperoxaluriasubtype3resultsfromaphaseisingledosestudyphyox4 AT schalkgesa correctiontonedosiraninprimaryhyperoxaluriasubtype3resultsfromaphaseisingledosestudyphyox4 AT russellkerry correctiontonedosiraninprimaryhyperoxaluriasubtype3resultsfromaphaseisingledosestudyphyox4 AT yushuli correctiontonedosiraninprimaryhyperoxaluriasubtype3resultsfromaphaseisingledosestudyphyox4 AT vrhnjakblaz correctiontonedosiraninprimaryhyperoxaluriasubtype3resultsfromaphaseisingledosestudyphyox4 |